PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- ONGLYZA
- Generic name / active ingredient
- saxagliptin
- Dosage-form class
- Dosage form and presentation as documented in the linked primary label
- Route
- Oral
- Record reviewed
- 2026-08-31
Copy from the pack in hand
Source-linked reading points
- 2.5 mg and 5 mg are amounts per tablet, not tablet counts. Kidney function and strong CYP3A4/5 inhibitors may affect professional decisions, but the site does not convert test results or medicine names into a strength.
- Severe persistent abdominal pain that may radiate to the back, with or without vomiting, may signal pancreatitis and needs timely clinical contact as directed by the label.
- Shortness of breath, orthopnoea, ankle or leg swelling, unusually rapid weight gain or unusual fatigue may signal heart failure, especially with prior heart failure or kidney problems.
- ONGLYZA, KOMBIGLYZE XR, QTERN and QTERNMET XR may share saxagliptin; do not combine from brand names. Hypoglycaemia risk may rise with insulin or a sulfonylurea.
Reviewed presentation examples — compare every field
- Equivalent to saxagliptin 2.5 mg per tablet; not an individual's tablet countNDC 0310-6100-30 / NDA 022350
- Equivalent to saxagliptin 5 mg per tablet; not an individual's tablet countNDC 0310-6105-30 / NDA 022350
- Equivalent to saxagliptin 2.5 mg per tablet; not an individual's tablet countDIN 02375842
- Equivalent to saxagliptin 5 mg per tablet; not an individual's tablet countDIN 02333554